Albert L. Reese Jr. - 08 Mar 2022 Form 4 Insider Report for Lexaria Bioscience Corp. (LEXX)

Role
Director
Signature
/Albert Reese Jr./
Issuer symbol
LEXX
Transactions as of
08 Mar 2022
Net transactions value
$0
Form type
4
Filing time
08 Mar 2022, 16:32:54 UTC
Previous filing
21 Jul 2021
Next filing
19 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding LEXX common shares 917 08 Mar 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LEXX Stock Options Award $0 +3,400 +100% $0.000000 6,800 08 Mar 2022 Common Shares 3,400 $3.39 Direct
holding LEXX Stock Options 3,400 08 Mar 2022 Common Shares 3,400 $4.80 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.